90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking, but we need to wait for the full data 11/12/2020 Health News, German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from...
Journal calls for use of objective data in root cause analyses of adverse medical events 10/21/2020 Health News, Wrong-site surgery, medication errors, and fires in operating rooms can be devastating for patients, providers,...
COVID-19 tracking tool provides latest local data, expert guidance 09/17/2020 Health News, The number of COVID-19 cases is surging in some regions and retreating in others, making...
New data offer insights on COVID treatments for people with cancer 07/22/2020 Health News, Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a...
Coronavirus data is funneled away from CDC, sparking worries 07/16/2020 Health News, Hospital data related to the coronavirus pandemic in the U.S. will now be collected by...
Analytics and data collecting spur helmet safety in football 05/15/2020 Health News, While no one is actually playing football right now, analytics and data collecting are contributing...
Combining viral genomics and public health data revealed new details about mumps outbreaks 02/11/2020 Health News, In 2016 and 2017, a surge of mumps cases at Boston-area universities prompted researchers to...
A single number helps data scientists find most dangerous cancer cells 01/24/2020 Health News, Stanford data scientists have shown that figuring out a single number can help them find...
New STAIRWAY Study Data Shows Potential for Extended Durability With Faricimab in Wet Age-Related Macular Degeneration (AMD) 11/01/2018 Medications, South San Francisco, CA -- October 27, 2018 -- Genentech, a member of the Roche...
G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer 10/23/2018 Medications, RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX),...